Delivery Order SPE2DB22D2206-SPE2DB25FDP83

Award Date 10/4/24
Potential Completion Date 10/28/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $12,894.24 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ENHERTU 100 MG VIALS. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's (DoD) medical treatment programs...
The U.S. Defense Logistics Agency (DLA) awarded a $8,058.85 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4565174830 - ENHERTU 100 MG VIALS. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which DLA Troop Support Medical uses to procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,110.80 firm fixed-price delivery order is for the supply of ENHERTU 100 MG vials, a specialty medication product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The contract is for the supply of ENHERTU 100 MG VIALS, a specialty pharmaceutical product, at a firm fixed price of $19,341.24. The delivery order has a period of performance through September 25, 2024 and does not...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $21,614.96 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG VIALS. This contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $17,777.00 firm fixed price contract is for ENHERTU 100 MG VIALS, a medication, with a period of performance through February 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,777.00 Firm Fixed Price Delivery Order contract is for the supply of ENHERTU 100 MG VIALS, a medical product. The contract has an ultimate completion date of February 11, 2025 and was awarded on January 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,099.62 firm-fixed-price delivery order is for the pharmaceutical product ENHERTU 100 MG VIALS, with a completion date of December 27, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ENHERTU 100 MG VIALS, a medical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $17,777.00, has an ultimate completion date of March 19, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $19,341.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENHERTU 100 MG vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDP83
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $13,016.24 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4566023708 ENHERTU 100 MG VIALS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a range of medical commodities to military treatment programs and facilities worldwide. The contract does not have a set-aside designation. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds several other notable IDCs, including one with the Department of Justice Federal Bureau of Investigation worth up to $750,000 through May 2024 for similar medical products and prescription drugs.

Generated 1/3/25, 9:31 AM